OTRIZAL 0.1

OTRIZAL 0.1

Xylometazoline is an arylalkyl  imidazoline.                    - Xylometazoline is a direct-acting sympathomimetic    
  with marked alpha-adrenergic activity. It is a
  vasoconstrictor which reduces swelling and congestion 
  when applied to mucous membranes.                  
 - The effect begins within 5 to 10 minutes of application 
   and lasts for up to 10 hours.
- Otrizal® nasal drops must be administered into the 
  nasal cavities, where it exerts a vasoconstrictive effect 
  leading to decongestion of the nasal and pharyngeal 
  mucosa, thus make it easier to breath through the nose 
  when suffering from cold or chill. 
- Otrizal® contains ingredients which prevent the drying 
  of nasal mucous membrane.

Each 1 ml of Otrizal®  0.05% nasal drops contains:                     
  Xylometazoline hydrochloride               0.5 mg 
- Each 1 ml of Otrizal®  0.1% nasal drops contains:                     
  Xylometazoline hydrochloride               1 mg


- Otrizal® should not be used in case of hypersensitivity                  
  to Xylometazoline hydrochloride or in the following cases:                                                                         
- After a transsphenoidal hypophysectomy.                     
- In case of dry rhinitis.                                                     
- Acute angle glaucoma.


 This drug should not be used with the following 
  medications because serious interactions may occur:                                                                                  - Drugs used for high blood pressure (hypertension).      
- Drugs used for heart failure and irregular heart beat.                                                                                     - Drugs for suppressing appetite.                                     
- Drugs used to induce labour called oxytocin. 

Otrizal® is considered well tolerated, and side effects may 
  appear as simple as:                                                         
- Temporary burning of stinging.                                                 - Dryness in the nose.                                                                  - Runny nose and sneezing may occur.                                 
- Burning sensation in the nose and throat.
 

Otrizal® should be used with caution in patients suffering 
  from hypertension, cardiovascular diseases, diabetes 
  mellitus and overactive thyroid (hyperthyroidism)

Otrizal® nasal drops: bottle of 10ml.

Store at temperature below 30 °C, and not use more than 
  one week without doctores advice.